Literature DB >> 26160100

HNF1B-associated clinical phenotypes: the kidney and beyond.

Detlef Bockenhauer1,2, Graciana Jaureguiberry3.   

Abstract

Mutations in HNF1B, the gene encoding hepatocyte nuclear factor 1β are the most commonly identified genetic cause of renal malformations. HNF1B was first identified as a disease gene for diabetes (MODY5) in 1997, and its involvement in renal disease was subsequently noted through clinical observations in pedigrees affected by MODY5. Since then, a whole spectrum of associated phenotypes have been reported, including genital malformations, autism, epilepsy, gout, hypomagnesaemia, primary hyperparathyroidism, liver and intestinal abnormalities and a rare form of kidney cancer. The most commonly identified mutation, in approximately 50 % of patients, is an entire gene deletion occurring in the context of a 17q12 chromosomal microdeletion that also includes several other genes. Some of the associated phenotypes, especially the neurologic ones, appear to occur only in the context of this microdeletion and thus may not be directly linked to HNF1B. Here we review the spectrum of associated phenotypes and discuss potential implications for clinical management.

Entities:  

Keywords:  Autism; Cystic kidney; Genital malformation; Gout; HNF1B; Hypomagnesemia; Renal dysplasia; Renal malformation; TCF2

Mesh:

Substances:

Year:  2015        PMID: 26160100     DOI: 10.1007/s00467-015-3142-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  64 in total

Review 1.  Transcriptional activators in hepatocytes.

Authors:  P F Johnson
Journal:  Cell Growth Differ       Date:  1990-01

2.  Missense mutations in EYA1 and TCF2 are a rare cause of urinary tract malformations.

Authors:  Bethan E Hoskins; Carl H Cramer; Velibor Tasic; Elijah O Kehinde; Shazia Ashraf; Radovan Bogdanovic; Julia Hoefele; Martin Pohl; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2007-12-08       Impact factor: 5.992

3.  Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction.

Authors:  H Nishigori; S Yamada; T Kohama; H Tomura; K Sho; Y Horikawa; G I Bell; T Takeuchi; J Takeda
Journal:  Diabetes       Date:  1998-08       Impact factor: 9.461

4.  Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations.

Authors:  Coralie Bingham; Sian Ellard; Trevor R P Cole; Katrin E Jones; Lisa I S Allen; Judith A Goodship; Timothy H J Goodship; Daniela Bakalinova-Pugh; Gavin I Russell; Adrian S Woolf; Anthony J Nicholls; Andrew T Hattersley
Journal:  Kidney Int       Date:  2002-04       Impact factor: 10.612

Review 5.  Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5.

Authors:  Yi-Zhi Chen; Qing Gao; Xue-Zhi Zhao; Ying-Zhang Chen; Craig L Bennett; Xi-Shan Xiong; Chang-Lin Mei; Yong-Quan Shi; Xiang-Mei Chen
Journal:  Chin Med J (Engl)       Date:  2010-11       Impact factor: 2.628

6.  Neonatal cholestatic jaundice as the first symptom of a mutation in the hepatocyte nuclear factor-1beta gene (HNF-1beta).

Authors:  Dominique Beckers; Christine Bellanné-Chantelot; Marc Maes
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

7.  Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease.

Authors:  C Bingham; M P Bulman; S Ellard; L I Allen; G W Lipkin; W G Hoff; A S Woolf; G Rizzoni; G Novelli; A J Nicholls; A T Hattersley
Journal:  Am J Hum Genet       Date:  2000-11-20       Impact factor: 11.025

8.  HNF1B mutations associate with hypomagnesemia and renal magnesium wasting.

Authors:  Shazia Adalat; Adrian S Woolf; Karen A Johnstone; Andrea Wirsing; Lorna W Harries; David A Long; Raoul C Hennekam; Sarah E Ledermann; Lesley Rees; William van't Hoff; Stephen D Marks; Richard S Trompeter; Kjell Tullus; Paul J Winyard; Janette Cansick; Imran Mushtaq; Harjeeta K Dhillon; Coralie Bingham; Emma L Edghill; Rukshana Shroff; Horia Stanescu; Gerhart U Ryffel; Sian Ellard; Detlef Bockenhauer
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

9.  Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions.

Authors:  Dalia Kasperavičiūtė; Claudia B Catarino; Krishna Chinthapalli; Lisa M S Clayton; Maria Thom; Lillian Martinian; Hannah Cohen; Shazia Adalat; Detlef Bockenhauer; Simon A Pope; Nicholas Lench; Martin Koltzenburg; John S Duncan; Peter Hammond; Raoul C M Hennekam; John M Land; Sanjay M Sisodiya
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

10.  Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract.

Authors:  Daw-Yang Hwang; Gabriel C Dworschak; Stefan Kohl; Pawaree Saisawat; Asaf Vivante; Alina C Hilger; Heiko M Reutter; Neveen A Soliman; Radovan Bogdanovic; Elijah O Kehinde; Velibor Tasic; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

View more
  30 in total

Review 1.  Liver involvement in kidney disease and vice versa.

Authors:  Karen Van Hoeve; Djalila Mekahli; Eva Morava; Elena Levtchenko; Peter Witters
Journal:  Pediatr Nephrol       Date:  2017-06-23       Impact factor: 3.714

Review 2.  Pharmacogenetics of posttransplant diabetes mellitus.

Authors:  P Lancia; T Adam de Beaumais; E Jacqz-Aigrain
Journal:  Pharmacogenomics J       Date:  2017-03-28       Impact factor: 3.550

Review 3.  Inherited and acquired disorders of magnesium homeostasis.

Authors:  Matthias Tilmann Florian Wolf
Journal:  Curr Opin Pediatr       Date:  2017-04       Impact factor: 2.856

Review 4.  Renal development in the fetus and premature infant.

Authors:  Stacy Rosenblum; Abhijeet Pal; Kimberly Reidy
Journal:  Semin Fetal Neonatal Med       Date:  2017-02-01       Impact factor: 3.926

Review 5.  The genetic basis of congenital anomalies of the kidney and urinary tract.

Authors:  Maayan Kagan; Oren Pleniceanu; Asaf Vivante
Journal:  Pediatr Nephrol       Date:  2022-02-04       Impact factor: 3.651

Review 6.  Kidney disease in children: latest advances and remaining challenges.

Authors:  John F Bertram; Stuart L Goldstein; Lars Pape; Franz Schaefer; Rukshana C Shroff; Bradley A Warady
Journal:  Nat Rev Nephrol       Date:  2016-02-01       Impact factor: 28.314

7.  Pathogenic variants in actionable MODY genes are associated with type 2 diabetes.

Authors:  Mathilde Boissel; Alexandre Bolze; Emmanuelle Durand; Amélie Bonnefond; Bénédicte Toussaint; Emmanuel Vaillant; Stefan Gaget; Franck De Graeve; Aurélie Dechaume; Frédéric Allegaert; David Le Guilcher; Loïc Yengo; Véronique Dhennin; Jean-Michel Borys; James T Lu; Elizabeth T Cirulli; Gai Elhanan; Ronan Roussel; Beverley Balkau; Michel Marre; Sylvia Franc; Guillaume Charpentier; Martine Vaxillaire; Mickaël Canouil; Nicole L Washington; Joseph J Grzymski; Philippe Froguel
Journal:  Nat Metab       Date:  2020-10-12

Review 8.  Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.

Authors:  Anthony J Bleyer; Matthias T Wolf; Kendrah O Kidd; Martina Zivna; Stanislav Kmoch
Journal:  Pediatr Nephrol       Date:  2021-05-22       Impact factor: 3.651

Review 9.  The Utility of Human Kidney Organoids in Modeling Kidney Disease.

Authors:  Aneta Przepiorski; Amanda E Crunk; Eugenel B Espiritu; Neil A Hukriede; Alan J Davidson
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

Review 10.  A practical approach to the genomics of kidney disorders.

Authors:  Eleanor Hay; Thomas Cullup; Angela Barnicoat
Journal:  Pediatr Nephrol       Date:  2021-03-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.